HD
Henry Dunant Hospital Center at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Henry Dunant Hospital Center takes part in 3 sessions at ESMO 2026 in Madrid. Its program centres on lung cancer care, especially preventing and managing common side effects of antibody-drug conjugates such as mouth sores, eye problems and lung inflammation. It also covers first-line immunotherapy choices in small cell and non-small cell lung cancer and the practical use of DLL3-targeted T-cell engagers.
| Organization | ESMO 2026 Attendance |
|---|---|
HD Henry Dunant Hospital Center Athens, Greece | |
Private general hospital in Athens, Greece. | Satellite Sun Oct 25 10:45–10:55 Satellite Sun Oct 25 11:05–11:35 Applying multidisciplinary approaches to real-world scenarios - Case study presentation followed by moderated group discussion and Q&A Lung & thoracic cancersNursing & supportive care Satellite Sun Oct 25 13:40–14:00 Practical Management of DLL3 T-Cell Engagers Lung & thoracic cancers Satellite Sun Oct 25 14:15–14:30 Faculty Roundtable and Audience Q&A Lung & thoracic cancers Satellite Mon Oct 26 18:30–20:00 Accord Healthcare - Navigating immunotherapy options in first-line ES-SCLC and NSCLC Lung & thoracic cancers Satellite Mon Oct 26 18:30–18:33 Welcome and introduction Lung & thoracic cancers Satellite Mon Oct 26 18:33–18:45 Overview of role of immunotherapy in the management of lung cancer Lung & thoracic cancers Satellite Mon Oct 26 19:45–19:55 Questions and answers Lung & thoracic cancers |
Instantly find 20 buyers from Henry Dunant Hospital Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction